$599

ATTD 2024 Key Press Releases Day 4 (March 9)

On the last day of ATTD 2024, two cardiometabolic-related news items have been observed: Dexcom announced its direct-to-watch feature for G7 will begin a phased launch in Q2 ’24 (view press release); and Medtronic announced new clinical and real-world MiniMed 780G AID data at ATTD 2024 (view press release). Below, FENIX provides highlights and insights for the respective news items.

This content is for Read Less members only.
Register
Already a member? Log in here